Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 6-7, 2010, Pages 522-526

  Namujju, Proscovia Bazanya ^a,b   Surcel, Helj Marja ^a   Kirnbauer, Reinhard ^c   Kaasila, Marjo ^a   Banura, Cecily ^d,e   Byaruhanga, Romano ^e,f   Muwanga, Moses ^g   Mbidde, Edward Katongole ^b   Koskela, Pentti ^a   Lehtinen, Matti ^a,h  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c Universitatsklinik fur Dermatologie   (Austria)

^d MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^e KAROLINSKA INSTITUTE   (Sweden)

^f St Francis Hospital Uganda   (Uganda)

^g Entebbe Hospital   (Uganda)

^h TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FINLAND; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; RISK FACTOR; SEROPREVALENCE; SOCIAL ASPECT; SOCIAL BEHAVIOR; UGANDA; VIRUS STRAIN; WART VIRUS; ALPHAPAPILLOMAVIRUS; BLOOD; CLASSIFICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK; STATISTICAL MODEL; VIROLOGY;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; ANTIBODIES, VIRAL; FEMALE; FINLAND; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UGANDA;

EID: 77953276752     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903582426     Document Type: Article

References (21)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base. 2.0 ed. Lyon: IARC; 2004.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
3. Clifford GM, Smith JS, Plummer M, Munoz N, Francesschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
4. Lehtinen M, Kaasila M, Pasanen K, Patama T, Palmroth J, Laukkanen P, et al. Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s. Int J Cancer 2006;119: 2612-2619
5. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan ET, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006;15:1274-1280
6. af Geijersstam V, Kibur M, Wang Z, Koskela P, Pukkala E, Schiller J, et al. Stability over time of serum antibody level to human papillomavirus type 16. J Infect Dis 1998;177:1710-1714
7. Dillner J, Kallings I, Brihmer C, Sikström B, Koskela P, Lehtinen M, et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996;173: 1394-1398
8. Banura C, Franceschi S, van Doorn LJ, Arslan A, Kleter B, Wabwire-Mangen F, et al. Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. Int J Cancer 2008;123:2180-2187
9. Simen-Kapeu A, Kataja V, Yliskoski M, Syrjänen K, Dillner J, Koskela P, et al. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis 2008;40: 745-751
10. Kjellberg L, Wang W, Wiklund F, Edlund K, Angstrom T, Lenner P, et al. Sexual behaviours and papillomavirus exposure in cervical neoplasia. A population-based case-control study. J Gen Virol 1999;80:391-398
11. Simen-Kapeu A, Rache LG, Kataja V, Yliskoski M, Bergeron C, Horo A, et al. Tobacco smoking and chewing as a risk for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Cote d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control 2009;20:163-170
12. Watt A, Garwood D, Jackson M, Younger N, Ragin C, Smikle M, et al. High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women. Infect Agents Cancer 2009;4:S11.
13. Slaymaker E, Bwanika JB, Kasamba I, Lutalo T, Maher D, Todd J. Trends in age at fi rst sex in Uganda: evidence from demographic and health survey data and longitudinal cohorts in Masaka and Rakai. Sex Transm Infect 2009;85: 12-19
14. Haavio-Mannila E, Kontula O, Kuusi E. Trends in sexual life. Working paper E 10/2001. Helsinki: The Population Research Institute; 2001.
15. Nikula M, Kopenen P, Haavoi-Mannila E, Hemminki E. Sexual health among adults in Finland: assessing risk and protective behaviour through a general health survey. Scand J Public Health 2007;35:298-305.
16. Clifton D. Combating cross-generational sex in Uganda. Washington DC: Population Reference Bureau; 2009. Available at: www.prb.org/Articles/2009/ crossgenerationalsex.aspx (accessed January 2010).
17. Lavikainen HM, Lintonen T, Kosunen E. Sexual behaviour and drinking style among teenagers: a population-based study in Finland. Health Promot Int 2009;24:2.
18. Twa-Twa J, Nakanaabi J, Sekimpi D. Underlying factors in female sexual partner instability in Kampala. Health Transit Rev 1997;7(Suppl):783-788
19. Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, et al. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst 2006;98:1045-1052 (Pubitemid 44288152)
20. Lehtinen M, Paavonen J. Effectiveness of preventive HPV vaccination. Int J STD AIDS 2003;14:787-792
21. Kaasila M, Koskela P, Kirnbauer R, Pukkala E, Surcel HM, Lehtinen M. Population dynamics of serologically identifi ed coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women. Int J Cancer 2009;125: 2166-2172